Faculty

Institution

Unit

Venue

Chi Lam Au Yeung

Instructor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gynecologic Oncology And Reproductive Medicine

Department Of Gynecologic Research

The University of Texas MD Anderson Cancer Center

Chi Lam Au Yeung is currently serving as a Gynecologic Oncology And Reproductive Medicine Instructor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Chi Lam Au Yeung

The University of Texas MD Anderson Cancer Center

Instructor

You can click a keyword to filter the displayed items

cancer research tumor biology ovarian cancer cell biology oncology gynecologic oncology oncogenes cancer cells cancer biology molecular cancer cancer discovery cancer letter pathology tumor microenvironment gynecologic cancers medicinal research cell death cancer treatment molecular biology enzyme inhibition ovarian cancer cells molecular cell biology cell metabolism surgical oncology cell migration cell regulation apoptosis cancer genetics disease progression microrna detection non-coding rna ovarian cancer progression physiology cell and molecular biology molecular and cellular biology cellular physiology cellular biochemistry cellular therapy death studies cell physiology cellular biology extracellular microvesicles cell trafficking hepatocellular carcinoma liver cancer colorectal cancer tumor suppressors cancer growth prognostic biomarkers biomarker target cancer risk cancer genomics signaling pathways secondary metabolism metabolic regulation functional modification tumor targeting cancer management chronic inflammation exosomal transfer cancer metastasis ovarian cancer metastasis molecular processes extracellular vesicles hepatocellular carcinoma cells immune cell response serous ovarian cancer improved overall survival potential biomarker next generation sequencing abstract 1939 ovarian cancer microenvironment ovarian cancer initiation obesity medicine metastasis cell signaling cell research metabolism autophagy extracellular matrix biochemistry clinical proteomics liver physiology stem cell research developmental cell lipids matrix biology stem cells breast cancer cellular differentiation metabolic syndrome molecular metabolism developmental biology tissue (biology) immunology carcinogenesis gene expression cell engineering pharmacology transcriptome systems biology molecular gastroenterology metabolic pathways molecular medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2085: Novel Obesity-Associated Adipokine Modulates the Malignant Phenotype of Endometrial Cancer Cells.. Cancer Research (2026)

Abstract 1363: Cancer Cell-Derived Exosomal Micrornas Enhance Immunosurveillance in Long-Term Survivors of High-Grade Serous Ovarian Cancer. Cancer Research (2025)

cancer lettermetastasistumor biologygynecologygynecologic cancerscancer researchmolecular cancerovarian cancercancer cellscell biologyoncogenescarcinogenesiscancer discoveryjama oncologytumor microenvironmentgynecologic oncologypathology

Abstract 4779: The Effects of Glutamine Deprivation on Ovarian Cancer Initiation and Progression. Cancer Research (2024)

Sammy Ferri-BorgognoKathryn LuBasant T. GamalChi Lam Au YeungErin SeeleyJavier A. GomezAkshay BasiJared K. BurksOlamide AnimasahunDeepak NagrathSamuel C. Mok

glutamine deprivationoncologyradiation oncologycancer researchcancer biologyovarian cancerpharmacologyovarian cancer initiationdisease progression

Abstract B067: Omentin: A Novel Immune Modulator in the Pro-Inflammatory Omental Microenvironment of High-Grade Serous Ovarian Cancer. Cancer Research (2024)

Chi Lam Au YeungKay-Pong YipKaren H LuDeepak NagrathSamuel C Mok

chronic inflammationmedicinenovel immune modulatorcancer biologycancer researchoncologycancer carecancer treatmentreproductive immunologyovarian cancerimmunologytumor targetinggynecologic oncologymedicinal researchpro-inflammatory omental microenvironmentinflammationcancer managementclinical researchhealth sciences

Abstract 1551: Mir-625-3P Enhances Chemosensitivity in Ovarian Cancer Cells Through Exosomal Export of Cisplatin and Paclitaxel. Cancer Research (2022)

cancer lettermetastasistumor biologygynecologygynecologic cancerscancer researchmolecular cancerovarian cancercancer cellscell biologyoncogenescancer discoverycarcinogenesiscell deathtumor microenvironmentgynecologic oncologypathology

Abstract 1440: Novel Imipridone Onc206 Suppresses Ovarian Cancer Progression Through Modulating Immune Cell Response. Cancer Research (2021)

Chi Lam Au YeungWen HuSammy Ferri-BorgognoRohinton S. TaraporeJoshua E. AllenKaren H. LuSamuel C. Mok

immune cell responsecolorectal canceroncologycancer researchcancer biologyovarian cancerimmunologypharmacologyovarian cancer progression

Extracellular Vesicles Derived From Ascitic Fluid Enhance Growth and Migration of Ovarian Cancer Cells. Scientific Reports (2021)

developmental biologyovarian cancer cellscell biologycancer cellsovarian cancercell migrationextracellular vesiclesextracellular microvesiclestumor microenvironmentgynecologic oncologycell trafficking

Abstract 2232: A Novel Immune Checkpoint Regulator in the Ovarian Cancer Microenvironment. Cancer Research (2020)

Sammy Ferri BorgognoTsz-Lun YeungCecilia S. LeungChi Lam Au YeungYing ZhuStephen T. WongSamuel C. Mok

cancer immunotherapyoncologycancer researchcancer biologyovarian cancer microenvironmentovarian cancerimmunotherapyimmunologypharmacologycancer treatmenthealth sciencesmedicinal research

Abstract 5321: Novel Imipridone Onc206 Inhibits Cell Proliferation and Induces Apoptosis in Uterine Serous Cancer Through Altering Mapk/Akt Signaling Network and Metabolic Reprogramming. Cancer Research (2020)

Chi Lam Au YeungWen HuLi ZhangSammy Ferri-BorgognoRohinton S. TaraporeJoshua E. AllenKaren H. LuSamuel C. Mok

cancer biologycell biologycell signalinguterine serous cancerpharmacologytumor biologyapoptosiscancer researchoncologycancer carecancer treatmentmetabolic reprogrammingimmunologycell deathmedicinal researchsignaling pathwaysoncogenesenzyme inhibitionclinical researchcancer genetics

Abstract 495: Leptin Facilitates Ovarian Cancer Metastasis Through Mir-28-3P and Matrix Metalloproteinase-1 in the Omental Tumor Microenvironment. Cancer Research (2018)

metastasiscancer lettertumor biologygynecologygynecologic cancerscancer researchmolecular cancerovarian cancercancer cellscell biologyoncogenescarcinogenesiscancer discoveryjama oncologytumor microenvironmentgynecologic oncologypathology

1
2
3
10 / page

Chi Lam Au Yeung

Instructor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gynecologic Oncology And Reproductive Medicine

Department Of Gynecologic Research

The University of Texas MD Anderson Cancer Center

Chi Lam Au Yeung is currently serving as a Gynecologic Oncology And Reproductive Medicine Instructor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Chi Lam Au Yeung

The University of Texas MD Anderson Cancer Center

Instructor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2085: Novel Obesity-Associated Adipokine Modulates the Malignant Phenotype of Endometrial Cancer Cells.. Cancer Research (2026)

Abstract 1363: Cancer Cell-Derived Exosomal Micrornas Enhance Immunosurveillance in Long-Term Survivors of High-Grade Serous Ovarian Cancer. Cancer Research (2025)

Abstract 4779: The Effects of Glutamine Deprivation on Ovarian Cancer Initiation and Progression. Cancer Research (2024)

Sammy Ferri-BorgognoKathryn LuBasant T. GamalChi Lam Au YeungErin SeeleyJavier A. GomezAkshay BasiJared K. BurksOlamide AnimasahunDeepak NagrathSamuel C. Mok

glutamine deprivationoncologyradiation oncologycancer researchcancer biologyovarian cancerpharmacologyovarian cancer initiationdisease progression

Abstract B067: Omentin: A Novel Immune Modulator in the Pro-Inflammatory Omental Microenvironment of High-Grade Serous Ovarian Cancer. Cancer Research (2024)

Chi Lam Au YeungKay-Pong YipKaren H LuDeepak NagrathSamuel C Mok

Abstract 1551: Mir-625-3P Enhances Chemosensitivity in Ovarian Cancer Cells Through Exosomal Export of Cisplatin and Paclitaxel. Cancer Research (2022)

Abstract 1440: Novel Imipridone Onc206 Suppresses Ovarian Cancer Progression Through Modulating Immune Cell Response. Cancer Research (2021)

Chi Lam Au YeungWen HuSammy Ferri-BorgognoRohinton S. TaraporeJoshua E. AllenKaren H. LuSamuel C. Mok

immune cell responsecolorectal canceroncologycancer researchcancer biologyovarian cancerimmunologypharmacologyovarian cancer progression

Extracellular Vesicles Derived From Ascitic Fluid Enhance Growth and Migration of Ovarian Cancer Cells. Scientific Reports (2021)

Abstract 2232: A Novel Immune Checkpoint Regulator in the Ovarian Cancer Microenvironment. Cancer Research (2020)

Sammy Ferri BorgognoTsz-Lun YeungCecilia S. LeungChi Lam Au YeungYing ZhuStephen T. WongSamuel C. Mok

cancer immunotherapyoncologycancer researchcancer biologyovarian cancer microenvironmentovarian cancerimmunotherapyimmunologypharmacologycancer treatmenthealth sciencesmedicinal research

Chi Lam Au YeungWen HuLi ZhangSammy Ferri-BorgognoRohinton S. TaraporeJoshua E. AllenKaren H. LuSamuel C. Mok

Abstract 495: Leptin Facilitates Ovarian Cancer Metastasis Through Mir-28-3P and Matrix Metalloproteinase-1 in the Omental Tumor Microenvironment. Cancer Research (2018)

1
2
3
10 / page